<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00355927</url>
  </required_header>
  <id_info>
    <org_study_id>DBSsed1-HMO-CTIL</org_study_id>
    <secondary_id>HTA3769</secondary_id>
    <nct_id>NCT00355927</nct_id>
  </id_info>
  <brief_title>Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.</brief_title>
  <official_title>Changes of the Neuronal Activity in the Subthalamic Nucleus Under Propofol Sedation During Stereotactic Electrode Implantation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to detect possible changes in the electrical activity of the
      Basal Ganglia related to sedation during deep brain stimulation surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Deep Brain Stimulation is commonly used for the treatment of movement disorders. Electrode
      positioning is usually performed under local anesthesia in fully awake patients. The
      procedure is uncomfortable to the patients who have to remain motionless during the whole
      surgery. Previous reports of electrode positioning under general anesthesia was found to be
      less accurate. This result was probably due to the effect of the anesthetics on the
      electrical activity of the Basal Ganglia.

      The purpose of this study is to detect possible changes in the electrical activity of the
      Basal Ganglia related to propofol sedation. Electrical activity of single neurons will be
      recorded before and after sedation.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>September 2006</start_date>
  <completion_date type="Anticipated">July 2008</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in the electrical activity of neuron cells of the basal ganglia in the examined patients</measure>
    <time_frame>Within 24 hours needed to analyse the data</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Movement Disorders</condition>
  <condition>Parkinson Disease</condition>
  <condition>Parkinsonian Disorders</condition>
  <condition>Dystonia</condition>
  <condition>Tourette Syndrome</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sedation with IV propofol</intervention_name>
    <description>Propofol(50 microgram/kg/min.), I.V. for 5-10 minutes, Until a level of light sedation is achieved</description>
    <other_name>DIPROFOL 1%; TAROPharmceutical Indusries Ltd. IL.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Candidate for Deep Brain Stimulation Surgery.

          -  Informed concent obtained.

        Exclusion Criteria:

          -  Suspected difficult intubation (by history or physical examination).

          -  Allergy to Propofol, eggs or soy-beans.

          -  History of sleep apnea syndrome.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dan Eimerl, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah Medical Organization</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zvi Israel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah Medical Organization</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hadassah Medical Organization</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Israel Z, Hassin-Baer S. Subthalamic stimulation for Parkinson's disease. Isr Med Assoc J. 2005 Jul;7(7):458-63. Review.</citation>
    <PMID>16011063</PMID>
  </reference>
  <reference>
    <citation>MaltÃªte D, Navarro S, Welter ML, Roche S, Bonnet AM, Houeto JL, Mesnage V, Pidoux B, Dormont D, Cornu P, Agid Y. Subthalamic stimulation in Parkinson disease: with or without anesthesia? Arch Neurol. 2004 Mar;61(3):390-2.</citation>
    <PMID>15023817</PMID>
  </reference>
  <reference>
    <citation>Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med. 1998 Oct 15;339(16):1105-11.</citation>
    <PMID>9770557</PMID>
  </reference>
  <verification_date>August 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 23, 2006</study_first_submitted>
  <study_first_submitted_qc>July 23, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 25, 2006</study_first_posted>
  <last_update_submitted>November 1, 2007</last_update_submitted>
  <last_update_submitted_qc>November 1, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 2, 2007</last_update_posted>
  <keyword>Deep brain stimulation</keyword>
  <keyword>Microelectrode recordings</keyword>
  <keyword>Basal Ganglia</keyword>
  <keyword>Sedation</keyword>
  <keyword>Propofol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Dystonia</mesh_term>
    <mesh_term>Tourette Syndrome</mesh_term>
    <mesh_term>Movement Disorders</mesh_term>
    <mesh_term>Parkinsonian Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

